Experience with independent radiological review during a topotecan trial in ovarian cancer
Open Access
- 1 May 1997
- journal article
- clinical trial
- Published by Elsevier in Annals of Oncology
- Vol. 8 (5) , 463-468
- https://doi.org/10.1023/a:1008241127883
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Phase II study of gemcitabine in patients with advanced pancreatic cancerBritish Journal of Cancer, 1996
- Advanced breast cancer: a phase II trial with gemcitabine.Journal of Clinical Oncology, 1995
- Docetaxel: an Active New Drug for Treatment of Advanced Epithelial Ovarian CancerJNCI Journal of the National Cancer Institute, 1995
- Current status of Taxotere® (docetaxel) as a new treatment in breast cancerBreast Cancer Research and Treatment, 1995
- Phase II trial of paclitaxel in patients with progressive ovarian carcinoma after platinum-based chemotherapy: a Gynecologic Oncology Group study.Journal of Clinical Oncology, 1994
- Oral etoposide is active against platinum-resistant epithelial ovarian cancer.Journal of Clinical Oncology, 1994
- Protracted oral etoposide in epithelial ovarian cancer: a phase II study in patients with relapsed or platinum-resistant diseaseBritish Journal of Cancer, 1994
- Topoisomerase I inhibitors: topotecan and irenotecanCancer Treatment Reviews, 1994
- Hexamethylmelamine/Altretamine as Second-Line Therapy for Epithelial Ovarian CarcinomaGynecologic Oncology, 1993
- Hexamethylmelamine as second-line therapy in platin-resistant ovarian cancerGynecologic Oncology, 1992